Epidural steroid injections demonstrated limited efficacy in reducing back pain and disability, according to a systematic ...

Meet suzetrigine, a non-opioid that promises to avoid addiction risk. But some experts say it can't replace opioids ...

For the first time in decades, a new class of painkiller has been approved by the US Food and Drug Administration (FDA).

Analysts said Nevro’s valuation was “inexpensive,” but the spinal cord stimulation business can benefit from Globus’ scale ...

GlobalData senior medical device analyst says the acquisition could see Nevro’s growth outside the US accelerate.

New blinded preliminary BRTX-100 data described this past Saturday at prestigious “2025 Winners in Industry Innovations in MSK Health” ...

Need heart chakra healing? Find out what the fourth chakra is and how to open it with the guidance of legit psychics on ...

Mereo BioPharma shifts focus to rare diseases with setrusumab showing strong results for Osteogenesis Imperfecta. Learn more on MREO stock here.

Needham reiterated a Hold rating on Globus Medical (NYSE:GMED), a medical device company with a market capitalization of $12 billion and an impressive revenue growth of 102% over the last twelve ...

The Lake County Sheriff's Office confirmed Saturday that they will be announcing the addition of a new canine next week, ...